Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Tinè

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Oncologist|March 22, 2024
Anticancer Drugs-Related Hypogonadism in Male Patients with Advanced Cancers on Active Treatment: A Systematic ReviewGiacomo Massa, Luca Zambelli, Ernesto Zecca, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 2, 2025
Exploring new predictors for hypertensive disorders of pregnancyDaniela Denis Di Martino, Elisa Sabattini, Marco Parasiliti, et al.
Tumori|June 16, 2026
End-of-life care: A retrospective study comparing sarcoma and patients with carcinomaLuca Zambelli, Giacomo Massa, Francesca Ricchini, et al.
Metabolites|January 21, 2023
The sFlt-1/PlGF Ratio in Patients Affected by Gestational Diabetes and SARS-CoV-2 InfectionDaniela Denis Di Martino, Chiara Maria Soldavini, Gabriele Rossi, et al.
Journal of Pain and Symptom Management|July 30, 2025
The Italian Version of the FAMCARE-P13 Questionnaire: A Validation StudyGiacomo Massa, Gabriele Tinè, Ernesto Zecca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2026
Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levelsChiara Colombo, Gabriele Tinè, Elena Palassini, et al.
Cancer Medicine|August 10, 2023
A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with DenosumabPaola Bracchi, Ernesto Zecca, Cinzia Brunelli, et al.
Breast (Edinburgh, Scotland)|October 19, 2025
Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancerErnesto Zecca, Luca Zambelli, Gabriele Tinè, et al.
Breast (Edinburgh, Scotland)|September 3, 2025
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event preventionGiacomo Massa, Noemi Simeone, Gabriele Tinè, et al.
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Non-invasive Maternal Hemodynamic Assessment to Classify High-Risk Pregnancies Complicated by Fetal Growth RestrictionSara Ornaghi, Andrea Caricati, Daniela Denis Di Martino, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Oncologist|March 22, 2024
Anticancer Drugs-Related Hypogonadism in Male Patients with Advanced Cancers on Active Treatment: A Systematic ReviewGiacomo Massa, Luca Zambelli, Ernesto Zecca, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 2, 2025
Exploring new predictors for hypertensive disorders of pregnancyDaniela Denis Di Martino, Elisa Sabattini, Marco Parasiliti, et al.
Tumori|June 16, 2026
End-of-life care: A retrospective study comparing sarcoma and patients with carcinomaLuca Zambelli, Giacomo Massa, Francesca Ricchini, et al.
Metabolites|January 21, 2023
The sFlt-1/PlGF Ratio in Patients Affected by Gestational Diabetes and SARS-CoV-2 InfectionDaniela Denis Di Martino, Chiara Maria Soldavini, Gabriele Rossi, et al.
Journal of Pain and Symptom Management|July 30, 2025
The Italian Version of the FAMCARE-P13 Questionnaire: A Validation StudyGiacomo Massa, Gabriele Tinè, Ernesto Zecca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2026
Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levelsChiara Colombo, Gabriele Tinè, Elena Palassini, et al.
Cancer Medicine|August 10, 2023
A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with DenosumabPaola Bracchi, Ernesto Zecca, Cinzia Brunelli, et al.
Breast (Edinburgh, Scotland)|October 19, 2025
Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancerErnesto Zecca, Luca Zambelli, Gabriele Tinè, et al.
Breast (Edinburgh, Scotland)|September 3, 2025
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event preventionGiacomo Massa, Noemi Simeone, Gabriele Tinè, et al.
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Non-invasive Maternal Hemodynamic Assessment to Classify High-Risk Pregnancies Complicated by Fetal Growth RestrictionSara Ornaghi, Andrea Caricati, Daniela Denis Di Martino, et al.
Pageof 3